Physician profile

Luis A Bowen

Interventional Cardiology · Dallas, TX

NPI 1902163033

$37,580.33

in general payments reported to CMS, 2019-2025

40 companies · $1,476 in 2025

The $1,476 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,496.44
Travel and Lodging$21.65

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $14,622.05 2019-2025 Sapien 3 Ultra Resilia
Abbott Laboratories $3,746.01 2019-2025 Esprit, Diamondback Peripheral, Thoratec Heartmate 3 Lvas Implant Kit
Shockwave Medical, INC $2,749.36 2020-2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Medtronic Vascular, INC. $2,293.75 2019-2020
Bard Peripheral Vascular, INC. $2,055.41 2020-2022
Boston Scientific Corporation $2,010.98 2019-2025 Peripheral Rotalink Plus, Innova Vascular, Opticross 35
Biotronik INC. $1,393.90 2020-2023 Orsiro Mission
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,225.48 2019-2024 Lifevest
Medtronic, INC. $1,148.40 2021-2025 Corevalve Evolut R, Onyx Frontier
Cardiovascular Systems INC. $1,141.36 2019-2021
Amgen INC. $830.73 2019-2024 Repatha
Janssen Pharmaceuticals, INC $592.13 2019-2022
Terumo Medical Corporation $586.12 2023-2025 Angio-Seal, Metacross Otw, Azur Cx Detachable
Merck Sharp & Dohme LLC $515.31 2021-2025 Verquvo
Astrazeneca Pharmaceuticals LP $510.75 2019-2024 Farxiga
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Alnylam Pharmaceuticals INC. $372.65 2021-2025 Onpattro, Amvuttra
Novartis Pharmaceuticals Corporation $343.60 2019-2024 Leqvio
Abiomed $331.34 2022-2025 Impella
Impulse Dynamics (USA) INC. $249.26 2025 Optimizer
E.R. Squibb & Sons, L.L.C. $147.52 2019-2025 Camzyos
Tactile Systems Technology INC $108.03 2021-2022
Angiodynamics, INC. $66.09 2019-2023 Auryon Laser System 100-120 Vac, Angiovac
Pfizer INC. $60.41 2021-2022
Arbor Pharmaceuticals, INC. $48.51 2019-2021
Chiesi USA, INC. $48.28 2021-2022
Amarin Pharma, INC. $38.86 2020-2022
Regeneron Healthcare Solutions, INC. $38.60 2019
Depuy Synthes Sales INC. $36.24 2024 Motoband, N/A
Biosense Webster, INC. $30.08 2025 Nuvision Ice Catheter
Itamar Medical INC $29.48 2022
Kestra Medical Technology Services, INC. $27.11 2025 Assure Wcd
Inspire Medical Systems, INC. $24.85 2025 Inspire
Sanofi-Aventis U.S. LLC $24.72 2020
Bracco Diagnostics INC. $24.53 2020
Cvrx, INC. $21.20 2023 Barostim Neo System
Novo Nordisk INC $21.14 2025 Wegovy
Azurity Pharmaceuticals, INC. $19.17 2023 Edarbi
Kiniksa Pharmaceuticals, LTD. $17.82 2021
Boehringer Ingelheim Pharmaceuticals, INC. $15.92 2023 Jardiance
Smith+Nephew, INC. $13.18 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$2,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Luis A Bowen

$37,580.33

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $1,476 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/2781998/luis-a-bowen

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.